Search








Clear Form

Professor Angel F Lopez

08 8302 7916
Royal Adelaide Hospital (RAH)
Immunology
Practice Responsibilities:Head, Human Immunology
Specialities:Immunopathology

Professor Angel F Lopez is an MD, PhD and Fellow of the Royal College of Pathologists. Since joining the IMVS and SA Pathology Professor Lopez continues to work in immunopathology conducting educational training and medical research. His major interest is understanding how growth factors or hormones produced by the immune system regulate inflammation and some cancers.

Prof Lopez is the author of more than 240 research publications and shares his research interests with a group of highly capable and enthusiastic colleagues. Their work has led to significant insights and breakthrough discoveries in understanding how soluble factors and their receptors work in health and in diseases such as allergic inflammation and some cancers. This path has led to new paradigms of cell signalling and has underpinned the development of new antibodies as diagnostic tools as well as potential therapeutics that can improve clinical practice.

He is the Head, Human Immunology, and leads a team of hard working and enthusiastic investigators internationally recognized for their work on growth factors and their receptors.   His team’s research has been supported uninterruptedly by the National Health and Medical Research Council of Australia since 1987, by the pharmaceutical industry, as well as by donations from generous donors.

In 2010, Professor Lopez became joint ‘South Australian Scientist of the Year’, in 2014 was elected Fellow of the Australian Academy of Science, and in 2017 elected Fellow of the Australian Academy of Health and Medical Sciences. In June 2017 he was made an Officer to the Order of Australia (AO) for his medical and scientific research in the areas of immunology, cell biology and innovative developments in cancer treatment. He is the co-founder, with Prof Michael P Brown, of the South Australian immunoGenomics Cancer Institute (SAiGENCI).